Expert Review of Pharmacoeconomics & Outcomes Research (ERPOR)

Expert Review of Pharmacoeconomics & Outcomes Research [ISSN 1473-7167]; [e-ISSN 1744-8379] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original research papers on health economics, pharmacoeconomics and outcomes, relating to all health technologies including; drugs, therapeutic approaches, medical devices, and prevention. Articles focus on the following key areas: Health technology assessment and health economics Health economic evaluation (cost-effectiveness), pharmacoeconomics and budget impact analyses Outcomes research including therapeutic outcomes and health preference research Quality of life, economic burden and cost of illness. The journal welcomes submissions of Original Research, Reviews, Systematic Reviews, Meta-analyses, Editorials and more. For guidelines on preparing each article type, please visit the instructions for authors page. Please note that the journal does not publish case reports or case series. Each review article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.

Expert Review of Pharmacoeconomics & Outcomes Research (ERPOR) is :-

• International, Peer-Reviewed, Open Access, Refereed, health economics, pharmacoeconomics and outcomes, health technologies including; drugs, therapeutic approaches, medical devices, prevention, Quality of life, economic burden, cost of illness , Online or Print , 10-issues-year Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1473-7167, E-ISSN: 1744-8379, Established: 2001, Impact Factor: 1.8
• Provides Crossref DOI

• Indexed in: Scopus, WoS

• Not indexed in DOAJ, PubMed, UGC CARE